AlphaYouSN
Insider selling
Sukumar Nagendran sold $892K of Taysha Gene Therapies, Inc. (TSHA) stock
Sukumar Nagendran, President and Head of R&D of Taysha Gene Therapies, Inc. (TSHA), sold 200,000 shares of TSHA stock worth $892K, per an SEC Form 4 filed Apr 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Apr 10, 2026, 3 days before it was made public.
TSHA has moved +12.2% since the trade date, from $4.49 to $5.04 (Sep 21, 2026 close).
- Traded
- Apr 10, 2026
- Disclosed
- Apr 13, 2026
- Filing delay
- 3 days
- Price since
- +12.2%
- Role
- President and Head of R&D
- Source
- SEC Form 4
More TSHA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.